Studies on forced degradation and solid state stability of tenofovir disoproxil orotate
Article Sidebar
-
Tenofovir Disoproxil Orotate, HPLC Method, Forced Degradation
Abstract
In order to develop a stability regulatory system for drug substances and degraded products, a forced degradation study is an essential part in the design of the method. As per ICH Guidelines Q1A in 1993, it was established as an essential requirement for the regulatory system to assess the stability of drugs and their degradation products under the degradation studies by force. These analytical methods are helpful in the development of stability, indicating the method by conducting the studies on forced degradation with their mechanism of degradation. Drug products by degradation and new drug substance by forced degradation conditions are more severe than a demonstration of specificity of stability indicating methods. The analytical method development is facilitated by those techniques for better understanding of (API) active pharmaceutical ingredients and (DP) drug products stability.
Full text article
References
Alsante, K. M., Hatajik, T. D., Lohr, L. L., Santafianos, D., Sharp, T. R. 2003. Solving impurity/degradation problems: case studies. Handbook of Isolation and Characterization of impurities in Pharmaceutical. 5:361–400.
Baertschi, S. W., Alsante, K. M. 2005. Pharmaceutical Stress Testing. page 99. The chemistry of the drug degradation, ISBN: 9780429136085.
Baertschi, S. W., Thatcher, S. R., Piechocki, J., Thoma, 2006. Sample presentation for photostability studies: problems and solutions. page 445. Pharmaceutical Photostability and Stabilization Technology, ISBN: 9780367390358.
Brummer, H. 2011. How to approach a forced degradation study. Life Sci Technol Bull, 31(14).
Dorman, D. E., Lorenz, L. J., Occolowitz, J. L., Spangle, A., Collins, M. W. 1997. Isolation and structure elucidation of the major degaradation products of cefaclor in the solid state. J Pharm Sci, 86(5):540–549.
European Medicines Agency 2003. ICH Stability testing of new drug substances and products Q1A (R2). Accessed on: 01 August 2003.
Harmon, P., Boccardi, G. 2005. Oxidative susceptibility testing in pharmaceutical stress testing predicting drug degradation. pages 168–191.
ICH Q3C (R3) Impurities 2002. Guidelines for Residual solvents. International Conference on Harmonization. pages 2–39. Accessed on: 9 August 2019.
Kovaříková, P., Klimeš, J., Dohnal, J., Tisovská, L. 2004. HPLC study of glimepiride under hydrolytic stress conditions. Journal of Pharmaceutical and Biomedical Analysis, 36(1):205–209.
Maheswaran, R. 2012. FDA perspectives: scientific considerations of forced degradation studies in ANDA submissions. Pharmaceutical Technology, 36(5):73–80.
Oyler, A. R., Segmuller, B. E., Sun, Y., Polshyna, A., Dunphy, R., Armstrong, B. L., Achord, P., Maryanoff, C. A., Alquier, L., Ichev, Y. V. 2012. Forced degradation studies of rapamycin: Identification of autoxidation products. Journal of Pharmaceutical and Biomedical Analysis, 59:194–200.
Prekodravac, B., Damm, M., Kappe, C. O. 2011. Microwave-assisted forced degradation using high-throughput microtiter platforms. Journal of Pharmaceutical and Biomedical Analysis, 56(5):867–873.
Ranjit, S., Rehman, Z. 2012. Current trends in forced degradation study for pharmaceutical product development. Journal of pharmaceutical and educational research, 3(1):54–63.
Rockville, M. D. 2004. Center for Biologics Evaluation and Research. Guidance for industry Q1E evaluation of stability data in the U.S, Food and Drug Administration Center for Biologics Evaluation and Research. pages 18–26.
Singh, S., Bakshi, M. 2000. Guidance on the conduct of stress tests to determine inherent stability of drugs. Pharma Tech, 24:1–14.
Trabelsi, H., Hassen, I. E., Bouabdallah, S., Bouzouita, K., Safta, F. 2005. Stability indicating LC method for the determination of pipamperone. Journal of Pharmaceutical and Biomedical Analysis, 39(5):914–919.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.